S100B Protein in Biological Fluids: A Tool for Perinatal Medicine
Open Access
- 1 December 2002
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 48 (12) , 2097-2104
Abstract
The diagnosis of perinatal insults currently relies on adequate documentation of general medical and obstetric factors and on radiologic and laboratory assessments. The measurement of brain constituents such as S100B protein may offer an alternative and direct indicator of cell damage in the nervous system when clinical and radiologic assessments are still silent and has the additional advantage of providing a quantitative indicator of the extent of brain lesions. S100B protein has been measured by several immunoassays in biological fluids (i.e., cerebrospinal fluid, blood, amniotic fluid, and urine) from fetuses and newborns at high risk of perinatal brain damage. S100B protein in biological fluids increased at an early stage when standard monitoring procedures were still silent in the study populations that later developed brain damage. S100B concentration was also significantly correlated with the extent of brain lesions. S100B protein appears to satisfy the criteria for a marker for brain injuries in perinatal medicine: (a) simple to perform measurements with good reproducibility; (b) detection in a variety of biological fluids, possibly reducing perinatal stress related to testing; (c) possible use in longitudinal monitoring because of its 1-h half-life; and (d) well-established use as an early and quantitative marker of brain lesions/damage. Finally, because of the neurotrophic role putatively played by S100B, its measurement in biological fluids at pre-/perinatal ages makes it a candidate for the laboratory evaluation of brain maturation.Keywords
This publication has 88 references indexed in Scilit:
- S100B protein cord blood levels and development of fetal behavioral states: a study in normal and small-for-dates fetusesThe Journal of Maternal-Fetal & Neonatal Medicine, 2002
- S-100B and neuron-specific enolase in serum of mild traumatic brain injury patients A comparison with healthy controlsActa Neurologica Scandinavica, 2001
- Brain S100A5 Is a Novel Calcium-, Zinc-, and Copper Ion-binding Protein of the EF-hand SuperfamilyJournal of Biological Chemistry, 2000
- Rapid Prenatal Diagnosis of Trisomy 21 by Polymerase Chain Reaction- Associated Analysis of Small Tandem Repeats and S100B in Chromosome 21Fetal Diagnosis and Therapy, 1998
- S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system.Stroke, 1987
- Mechanism of action of S-100 protein(s) on brain microtubule protein assemblyBiochemical and Biophysical Research Communications, 1984
- Effect of S‐100 protein on microtubule assembly—disassemblyFEBS Letters, 1983
- Effect of S‐100 proteins and calmodulin on Ca2+‐induced disassembly of brain microtubule proteins in vitroFEBS Letters, 1982
- The nervous system-specific S-100 antigen in cerebrospinal fluid of multiple sclerosis patientsNeuroscience Letters, 1979
- A soluble protein characteristic of the nervous systemBiochemical and Biophysical Research Communications, 1965